ITCI (NASDAQ) - Intracellular Th

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US46116X1019
Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also involved in developing Lumateperone, which is in Phase 3 clinical trial for the treatment of various depressive disorders, as well as additional neuropsychiatric indications. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease, heart failure, CNS, and other disorders; ITI-1284 for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression, anxiety, and sleep disorders. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. Web URL:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for ITCI (NASDAQ) - Intracellular Th


Market Cap in USD 5,641m
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 2014-01-07


Fundamental -1.79
Dividend -
Performance 5y 6.26
Rel. Performance vs Sector 1.14
Analysts 4.46
Fair Price Total Ret. 56.52
Fair Price DCF todo


Growth TTM 24.73%
CAGR 5y 19.28%
CAGR / Mean Drawdown 5y 0.71
Sharpe Ratio TTM 0.50
Alpha vs SP500 TTM 5.65
Beta vs SP500 5y weekly 0.99
CAPM 7.47%
Average Daily Range 2m 2.93%
Reversal Oscillator 21.19
Volatility GJR Garch 1y 109.95%
Price / SMA 50 -6.17%
Price / SMA 200 -3.11%
Current Volume 492.5k
Average Volume 20d 632.7k


Yield TTM 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Consistency of Dividends all time 0.0%